VOYA Investment Management
ATOS icon

VOYA Investment Management’s Atossa Therapeutics ATOS Stock Holding History

VOYA Investment Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,790
Closed -$28.2K – 2655
2025
Q1 		$28.2K Sell
2,790
-159
-5% -$1.93K ﹤0.01% 2600
2024
Q4 		$41.8K Sell
2,949
-141
-5% -$2.75K ﹤0.01% 2706
2024
Q3 		$70.5K Hold
3,090
– – ﹤0.01% 2726
2024
Q2 		$55.2K Buy
+3,090
New +$68.4K ﹤0.01% 2782
2022
Q2 		– Sell
-2,928
Closed -$55K – 2777
2022
Q1 		$55K Hold
2,928
– – ﹤0.01% 2585
2021
Q4 		$70K Sell
2,928
-148
-5% -$5.42K ﹤0.01% 2715
2021
Q3 		$150K Hold
3,076
– – ﹤0.01% 2651
2021
Q2 		$292K Buy
+3,076
New +$163K ﹤0.01% 2389

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VOYA Investment Management's ATOS Position: Q2 2025 in Review

VOYA Investment Management sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 2,790 shares — an estimated $28.2K sold.

VOYA Investment Management first reported a position in ATOS in Q2 2021 and held it in 8 quarters. The position peaked at $292K in Q2 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • VOYA Investment Management reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 2,790 Atossa Therapeutics shares in Q2 2025, an estimated $28.2K.
  • VOYA Investment Management first reported a position in Atossa Therapeutics in Q2 2021 and held it in 8 quarters.
  • VOYA Investment Management's Atossa Therapeutics position peaked at $292K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.